Baptist Health Miami Cancer Institute — Miami, Florida

Baptist Health Miami Cancer Institute is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Baptist Health Miami Cancer Institute has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Urinary Incontinence, Urge, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.

Sponsors: Uro Medical Corporation, Miltenyi Biomedicine GmbH, Pfizer.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baptist Health Miami Cancer Institute?

Baptist Health Miami Cancer Institute has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baptist Health Miami Cancer Institute conducted?

Baptist Health Miami Cancer Institute has 4 clinical trials on record, with 2 currently active. Their work covers Urinary Incontinence, Urge, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.

Is Baptist Health Miami Cancer Institute accredited by Crixeo Health?

Baptist Health Miami Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baptist Health Miami Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.